AU1272295A - Proinsulin-like compounds - Google Patents
Proinsulin-like compoundsInfo
- Publication number
- AU1272295A AU1272295A AU12722/95A AU1272295A AU1272295A AU 1272295 A AU1272295 A AU 1272295A AU 12722/95 A AU12722/95 A AU 12722/95A AU 1272295 A AU1272295 A AU 1272295A AU 1272295 A AU1272295 A AU 1272295A
- Authority
- AU
- Australia
- Prior art keywords
- proinsulin
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK139993A DK139993D0 (en) | 1993-12-17 | 1993-12-17 | PRODUCT |
DK1399/93 | 1993-12-17 | ||
DK140093A DK140093D0 (en) | 1993-12-17 | 1993-12-17 | PRODUCT |
DK1400/93 | 1993-12-17 | ||
DK029/94 | 1994-01-07 | ||
DK2994 | 1994-01-07 | ||
PCT/DK1994/000471 WO1995016708A1 (en) | 1993-12-17 | 1994-12-16 | Proinsulin-like compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1272295A true AU1272295A (en) | 1995-07-03 |
Family
ID=27220342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU12722/95A Abandoned AU1272295A (en) | 1993-12-17 | 1994-12-16 | Proinsulin-like compounds |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1272295A (en) |
WO (1) | WO1995016708A1 (en) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0150565B1 (en) * | 1995-02-15 | 1998-08-17 | 김정재 | A process for preparing human proinsulin by recombinant dna technology |
CA2223272A1 (en) * | 1995-05-05 | 1996-11-07 | Ronald Eugene Chance | Single chain insulin with high bioactivity |
US5622932A (en) * | 1995-05-05 | 1997-04-22 | Eli Lilly And Company | IGF-1 superagonists |
US7378390B2 (en) | 1999-12-29 | 2008-05-27 | Novo Nordisk A/S | Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
US6521738B2 (en) | 1999-12-29 | 2003-02-18 | Novo Nordisk A/S | Method for making insulin precursors and insulin precursor analogs |
DE60044728D1 (en) | 1999-12-29 | 2010-09-02 | Novo Nordisk As | METHOD FOR THE PRODUCTION OF INSULIN FORECASTS AND ANALOGS OF INSULIN PROCESSORS WITH IMPROVED FERMENTATION EXPORTS IN YEAST |
CN100432104C (en) * | 1999-12-29 | 2008-11-12 | 诺沃挪第克公司 | Method for making insulin precursors and insulin precursor analogs |
US6777207B2 (en) | 1999-12-29 | 2004-08-17 | Novo Nordisk A/S | Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
US7105314B2 (en) | 2001-04-02 | 2006-09-12 | Novo Nordisk A/S | Method for making human insulin precursors |
WO2002100887A2 (en) * | 2001-06-08 | 2002-12-19 | Novo Nordisk A/S | Method for making insulin precursors and insulin precursor analogs |
EP2261250B1 (en) | 2001-12-21 | 2015-07-01 | Human Genome Sciences, Inc. | GCSF-Albumin fusion proteins |
JP5697831B2 (en) * | 2003-12-03 | 2015-04-08 | ノヴォ ノルディスク アー/エス | Single chain insulin |
KR101729986B1 (en) | 2006-09-22 | 2017-04-25 | 노보 노르디스크 에이/에스 | Protease resistant insulin analogues |
US8946148B2 (en) | 2007-11-20 | 2015-02-03 | Ambrx, Inc. | Modified insulin polypeptides and their uses |
BRPI1014760B8 (en) | 2009-06-26 | 2021-05-25 | Novo Nordisk As | preparation comprising insulin, nicotinamide and arginine |
WO2012080362A1 (en) | 2010-12-14 | 2012-06-21 | Novo Nordisk A/S | Preparation comprising insulin, nicotinamide and an amino acid |
EP2651432A1 (en) | 2010-12-14 | 2013-10-23 | Novo Nordisk A/S | Fast-acting insulin in combination with long-acting insulin |
EP2768520A4 (en) | 2011-10-18 | 2015-07-15 | AmideBio LLC | Chemically and thermodynamically stable insulin analogues and improved methods for their production |
CN109180802A (en) * | 2011-12-15 | 2019-01-11 | 爱德迪安(北京)生物技术有限公司 | Compound, composition with hypoglycemic effect and application thereof |
WO2013186138A1 (en) | 2012-06-14 | 2013-12-19 | Novo Nordisk A/S | Preparation comprising insulin, nicotinamide and arginine |
WO2014088836A1 (en) | 2012-12-03 | 2014-06-12 | Merck Sharp & Dohme Corp. | O-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues |
EP2986315A4 (en) | 2013-04-17 | 2017-03-01 | AmideBio LLC | Chemically and thermodynamically stable insulin analogues and improved methods for their production |
TW201605470A (en) | 2013-10-04 | 2016-02-16 | 默沙東藥廠 | Glucose-responsive insulin conjugates |
GB201321489D0 (en) | 2013-12-05 | 2014-01-22 | Chemical & Biopharmaceutical Lab Of Patras S A | Biologically active insulin derivatives |
WO2016081670A2 (en) | 2014-11-21 | 2016-05-26 | Merck Sharp & Dohme Corp. | Insulin receptor partial agonists |
WO2016144658A1 (en) | 2015-03-10 | 2016-09-15 | Merck Sharp & Dohme Corp. | Process for preparing recombinant insulin using microfiltration |
US10745457B2 (en) | 2015-09-02 | 2020-08-18 | Merck Sharp & Dohme Corp. | Process for obtaining insulin with correctly formed disulfide bonds |
WO2017189342A1 (en) | 2016-04-26 | 2017-11-02 | Merck Sharp & Dohme Corp. | Insulin dimer-incretin conjugates |
US10953076B2 (en) | 2016-05-24 | 2021-03-23 | Merck Sharp & Dohme Corp. | Insulin receptor partial agonists and GLP-1 analogues |
US10689430B2 (en) | 2016-05-25 | 2020-06-23 | Merck Sharp & Dohme Corp. | Insulin receptor partial agonists |
EP3272877A1 (en) | 2016-07-18 | 2018-01-24 | ETH Zurich | B-cell-mimetic cells |
JP2019520837A (en) | 2016-07-18 | 2019-07-25 | イーティーエイチ・チューリッヒ | Sac cell mimetic cells |
AU2017322552B2 (en) | 2016-09-06 | 2021-12-02 | Chemical & Biopharmaceutical Laboratories Of Patras S.A. | Proinsulin derivatives |
EP3600381A4 (en) | 2017-03-23 | 2021-06-16 | Merck Sharp & Dohme Corp. | Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes |
KR20220121833A (en) | 2019-12-30 | 2022-09-01 | 간 앤 리 파마슈티칼스 컴퍼니, 리미티드 | insulin derivatives |
BR112022013042A2 (en) | 2019-12-30 | 2022-10-18 | Gan & Lee Pharmaceuticals Co Ltd | FORMULA B COMPOUND, PHARMACEUTICAL FORMULATION, PHARMACEUTICAL COMPOSITION, METHOD TO TREAT OR PREVENT HYPERGLYCEMIA, DIABETES AND/OR OBESITY |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1285023A (en) * | 1968-08-09 | 1972-08-09 | Novo Terapeutisk Labor As | Improvements in or relating to injectable insulin preparations |
AU612141B2 (en) * | 1987-02-25 | 1991-07-04 | Novo Nordisk A/S | Novel insulin derivatives |
ES2061797T3 (en) * | 1988-06-23 | 1994-12-16 | Hoechst Ag | MINI-PROINSULIN, ITS PREPARATION AND EMPLOYMENT. |
ATE93238T1 (en) * | 1988-07-20 | 1993-09-15 | Novo Nordisk As | HUMAN INSULIN PLANTS AND PREPARATIONS THEREOF. |
US5158875A (en) * | 1989-08-25 | 1992-10-27 | Amgen Inc. | Production of biologically active insulin-like growth factor i from high expression host cell systems |
WO1993023067A1 (en) * | 1992-05-08 | 1993-11-25 | Thomas Jefferson University | Igf-1 analogs |
-
1994
- 1994-12-16 WO PCT/DK1994/000471 patent/WO1995016708A1/en active Application Filing
- 1994-12-16 AU AU12722/95A patent/AU1272295A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1995016708A1 (en) | 1995-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1272295A (en) | Proinsulin-like compounds | |
AU6971794A (en) | Novel compounds | |
AU7583794A (en) | 1-amino-ethylindole-derivatives | |
AU6001594A (en) | Imidazoazines | |
AU6710294A (en) | Tetrahydro-beta-carbolines | |
AU6705294A (en) | Tetrahydro-pyrido-indole | |
AU3803593A (en) | Compounds | |
AU7220794A (en) | Detergent-package combination | |
AU5261093A (en) | Aminoalkylphenyl compounds | |
AU5798394A (en) | Thiadiazinones | |
AU6259294A (en) | Life-savingfloat | |
AU1274295A (en) | Heteroarylpyrroles | |
AU6389494A (en) | Tv-projector | |
AU8104694A (en) | Bagbottle | |
AU3048492A (en) | New compounds | |
AU5394594A (en) | New compounds | |
AU6971594A (en) | Cyclobutylazoles | |
AU6427194A (en) | Aza-androstane-17beta -carboxamides | |
AU3696093A (en) | Aquamate | |
AU7285994A (en) | Suncap | |
AU5780894A (en) | Crankhead | |
AU3759793A (en) | Compounds | |
AU6169294A (en) | 15-oxasterols as hypocholesterolemics | |
AU6044594A (en) | 5-aminoacetylaminosulfonanilide compound | |
AU5979694A (en) | Depsidone compound |